Pediatrics
Showing 401-500 of 531 Results
-
David Alex Sarno
Adjunct Lecturer, Pediatrics - Cardiology
BioDavid Sarno is a lecturer in the Department of Pediatrics at the school of medicine, specializing in virtual reality-based education. David founded Lighthaus Inc., a VR education company in 2013 while a John S. Knight journalism fellow at Stanford. Before that, David was a technology journalist at the Los Angeles Times for seven years. He holds an MFA in Creative Writing from the University of Iowa and a B.A. in Computer Science from Yale University.
-
Noelle Schlenk
Rsch Data Analyst 1, Pediatrics - Rheumatology
BioNoelle is a Research Data Analyst for the Immune Behavioral Health Clinic / research team. She applies her expertise in statistics and bioinformatics to investigate genetic components of Pediatric Acute-onset Neuropsychiatric Syndrome (PANS).
Noelle holds a master's degree in Ecology & Evolutionary Biology from the University of Kansas. -
Jennifer Chie Schymick
Clinical Assistant Professor (Affiliated), Pediatrics - Genetics
BioPROFESSIONAL EDUCATION
∗ Medical Genetics Fellowship Stanford University (2018-2020)
∗ General Internal Medicine Residency University of Toronto (2013-2018)
∗ M.D. University of California Irvine (2009-2013)
∗ Ph.D. Oxford University & National Institutes of Health (2005-2009)
∗ B.Sc. Massachusetts Institute of Technology (1998-2002) -
Zachary M. Sellers, MD, PhD
Adjunct Professor, Pediatrics - Gastroenterology
BioDr. Sellers is a pediatric physician-scientist and research and clinical development consultant. As a pediatric gastroenterologist and ion channel physiologist, Dr. Sellers' work in academia and pharma over the last 20 years has focused on improving the lives of individuals with complex and rare diseases through providing cutting-edge clinical care and advancing research and drug development. Dr. Sellers previously led a basic and translational research laboratory at Stanford, focused on epithelial ion transport and acid-base regulation using a variety of human and animal models. He is a firm believer in the exponential impact of team science and is adept working in multi-disciplinary and cross-functional teams. He seeks out strategic partnerships and opportunities that can leverage his expertise and leadership to advance innovative therapies for areas of high unmet need and to support the development of the next generation of physician-scientists. Dr. Sellers received his BS (Animal Physiology and Neuroscience) and BA (Japanese Studies) from the University of California. San Diego, his MD and PhD (Molecular and Integrative Physiology) from the University of Illinois at Urbana-Champaign, and was trained in Pediatrics and Pediatric Gastroenterology, Hepatology, and Nutrition at Stanford, where he was previously a faculty member and attending physician. He held multiple leadership positions at Stanford, including Associate Chief of Research in Gastroenterology, Director of the Stanford Children's Pancreas Program, Lead Gastroenterologist for the CF Program, Director of the CFTR Phenotyping and Theratyping Program, and Physician-Scientist Advisor for the Pediatrics Residency Program.
-
Aditi Sharma
Basic Life Research Scientist, Pediatrics - General Pediatrics
Current Role at StanfordResearch Scientist
-
Victoria "Vicki" Spencer
Adm Assoc 4, Pediatrics - Peds/Critical Care
BioA graduate of Purdue University, Vicki brings over 20 years of executive administrative support experience to her position at Stanford Medicine.
Prior to taking this role, Vicki supported the Chief Medical Officer and Chief Dental Officer for a group of Federally Qualified Health Centers (FQHC). She has also provided executive support to individuals in the field(s) of healthcare, food equity, and pre-clinical drug development.
Her passions are health equity and whole-system integrated care. -
Han Sun
Postdoctoral Scholar, Genetics
Biostatistician 2, Pediatrics - EndocrinologyBioHan had been a postdoc with Dr. Steinmetz at the genetics department for five years, working on both cancers and heart diseases, trying to understand the mechanisms linking from variants to disease phenotypes. This led to a few very interesting findings of aberrant splicing regulation, such as splicing-mediated readthrough stabilization (SRS), one more mechanism for oncogene activation in multiple types of cancers, and tissue-specific splicing of a mitochondrial inner membrane protein, suggesting a molecular connection between deficiency in energy-supplying and dilated cardiomyopathy.
After being a senior computational biologist with Dr. Gloyn, who has been dedicated to the research of type 2 diabetes for decades, Han switched to the field of this multifactorial metabolic disease. It did take some courage to make such a switch at his post-postdoc stage, however, Han has a consistent interest in studying PG&E, which is not pacific gas and electric nearby, but the interaction between phenotype, genotype, and environment. With years of hands-on experience in statistical modeling and the analysis of next-generation sequencing and mass spectrometry data, in addition to a good understanding of disease genetics, cancer biology, and systems biology, Han is highly confident that he will enjoy the adventure and contribute to our understanding of diabetes. -
Jacqueline Sunderland
Adm Assoc 4, Pediatrics - Endocrinology
Current Role at StanfordAdministrative Associate, Pediatric Endocrinology & Diabetes
-
Swaraj Thaman
Life Science Research Professional, Pediatrics - Endocrinology
Current Role at StanfordLife Science Research Professional 1, Translational Genomics of Diabetes Laboratory, Department of Pediatrics - Endocrinology, School of Medicine
-
George F Tidmarsh
Adjunct Professor, Pediatrics - Neonatology
BioDr. Tidmarsh received M.D. and Ph.D. from Stanford University, where he also completed fellowship training in Pediatric Oncology and Neonatology and is currently Adjunct Faculty of Pediatrics and Neonatology. He served as clinical faculty at Stanford for a number of years after fellowship prior to devoting his full time to clinical research and development in order to bring new treatments through the FDA approval process. Dr. Tidmarsh was President, Chief Executive Officer, Secretary and a Director of La Jolla Pharmaceutical Company from January 2012 until November 2019. While at La Jolla, Dr. Tidmarsh helped discover the use of angiotensin II for the treatment of shock and led all aspects of the development including approval by the US FDA and the EMA for the treatment of patients suffering from distributive shock. He also led the development of artesunate for the treatment of severe malaria, now pending action for potential approval at the FDA. Dr. Tidmarsh has over 30 years of experience in biotechnology, including the successful clinical development of three FDA-approved drugs. He previously served as the Chief Executive Officer of Horizon Pharma, Inc., a company he founded in 2005. While at Horizon, he led all aspects of development of Duexis, which was approved by the FDA for the treatment of rheumatoid arthritis. He also founded Threshold Pharmaceuticals, Inc. and held senior positions at Coulter Pharmaceutical, Inc. (acquired by GlaxoSmithKline) and SEQUUS Pharmaceuticals, Inc. (acquired by Johnson & Johnson). While at Coulter and SEQUUS, Dr. Tidmarsh led the clinical development of BEXXAR and Doxil, respectively, two FDA-approved anti-cancer agents.
At Stanford, Dr. Tidmarsh is devoted to teaching clinical research and development to residents, fellows and junior faculty. In addition, he is working to help improve the quality of medical care through various efforts which include serving on the board of Lucile Packard Foundation for Children's Health. -
Sarina Tom
Associate Director for Education Operations, Pediatrics
Current Role at StanfordEducation Operations Manager
Office of Pediatric Education
Stanford Department of Pediatrics -
Yousef Turshani MD FAAP
Clinical Assistant Professor (Affiliated), Pediatrics - General Pediatrics
BioYousef Turshani MD is Chief Medical Officer at San Mateo Medical Center, part of the County of San Mateo leadership team. He cares for pediatrics outpatients at Fair Oaks Health Center in Redwood City. He is a pediatric nocturnist at San Francisco General Hospital, where he holds a faculty appointment at UCSF. Dr Turshani facilitates the County Health connection with Stanford va iMPACt: Mid-peninsula Pediatric Advocacy Coalition. https://med.stanford.edu/childhealthequity/engagement/impactcoalition.html
Born to Libyan immigrants in Louisville, KY, he developed his passion for teaching and global health as a medical student at the University of Chicago. His pediatric residency began with UCLA's "Community Health and Advocacy Training" and completed at UCSF in 2009 when he joined the UCSF faculty as a neonatal hospitalist at California Pacific Medical Center, directing the newborn nursery rotation for medical students. He spent the next part of his career as a global health clinician until returning to California in 2014 with his wife, a human rights attorney, to continue their social justice work domestically.
Professional Affiliations:
-UC-San Francisco: Associate Clinical Professor [volunteer], Department of Pediatrics. Affiliate Faculty member at Institute for Global Health Sciences, HEAL Initiative Mentor
-American Board of Pediatrics: Director
International experiences include
-Former Chair of Pediatrics at the only hospital on Saipan (Commonwealth of the Northern Mariana Islands)
-HIV consultant in Zimbabwe for "Doctors without Borders" collaborating with ICRC, UNICEF and partners to hand over a Pediatric HIV project to the Ministry of Health.
-Evaluating community health workers in Nicaragua
-Disaster relief work in Iceland and Peru
